Gabe Castaneda joins as new chief revenue officer, and acclaimed healthcare trailblazer Dr. Cheryl Pegus is named executive board chair FlyteHealthhas hired Gabe Castaneda as chief revenue officer, strengthening the executive team to position the company for continued growth. FlyteHealth has also named Dr. Cheryl Pegus as executive board chair. https://mma.prnewswire.com/media/2528325/FLYTEHEALTH_Gabe_Headshot.jpg Castaneda is an experienced […]

ISM-001 is a potential first-in-class antibody that may lead to a new treatment pathway for patients with peripheral arterial disease (PAD)Company enters strategic collaboration with Pfizer Ignite to accelerate IND-enabling regulatory studies IsomAb Ltd,a UK-based biotechnology company developing isoform-specificdisease modifying antibody treatments for serious and life-threatening diseases, today announced the nomination of a Development Candidate

Anovo robotic surgical platform is the world’s first single port robotics platform approved for ventral hernia repairs in the US Momentis Surgical Ltd., a medical device company dedicated to transforming robot-assisted surgery with its proprietary technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) Clearance to its Anovo™ robotic surgical

Clean-label HoneyGum portfolio combines pure liquid honeywith natural active wellness ingredients Gummy supplement manufacturer TopGum Industries, Ltd. (TASE: TPGM) unveils HoneyGum, a line of all-natural, honey-based functional gummies. The new product joins the company’s rapidly expanding portfolio of advanced dietary supplement gummies. https://mma.prnewswire.com/media/2529822/TopGum.jpg What makes this gummy unique is TopGum’s utilization of pure, high-dose liquid

Rye Pollen and Phytosterol Combo Eases Nocturia in Men A botanical combo targeting prostate health could offer men relief of the common problem of frequent nighttime urination, according to results from a recent consumer study. The natural complex, Plasys300™, by the nutraceutical innovators Pharmactive Biotech Products, S.L.U., was formulated specifically to support men’s prostate and

Tetrous, Inc., a Sherman Oaks start up focused on bone-to-tendon healing following orthopedic surgery, announced today thata fourth patent (U.S. Patent Number 12,115,279) specifically related to the EnFix family of demineralized cortical bone fiberimplants and their method of manufacture has been issued by the United States Patent and Trademark Office. https://mma.prnewswire.com/media/2530488/TAC_O_on_Inserter.jpg Our growing intellectual property

Neurotech Reports announced that executives from several emerging neurotechnology startups will present for the first time at the 2024 Neurotech Leaders Forumin San Francisco, November 6-7. Among the new presenters are Paxos Medical, a firm that has developed a novel neuromodulation therapy for non-obstructive urinary retention. Also presenting for the first time will be Katya

V2X, Inc., (NYSE: VVX), a leading provider of global mission solutions, will report third quarter 2024 financial results on Monday, November 4, 2024, after market close. Senior management will conduct a conference call at 4:30 p.m. ET that same day. https://mma.prnewswire.com/media/1852552/V2X_Color_Logo.jpg U.S.-based participants may dial in to the conference call at 877-506-6380, while international participants

Lomond Therapeutics, a subsidiary of Eilean Therapeutics LLC, a biopharmaceutical company dedicated to discovering and developing best-in-class and first-in-class small molecule inhibitors to target escape mutations in hematologic and solid malignancies, today announced that the U.S. Food and Drug Administration (FDA) has cleared Lomond’s Investigational New Drug (IND) application for a Phase 1 multicenter study

— Revel operates largest network of public fast charging stations in New York City — Agreement provides Toyota and Lexus customers access to complimentary charging at Revel charging stations — Toyota Ventures investment into Revel supports adoption of electrified mobility solutions Toyota Motor North America (Toyota) and Revel announced today an agreement to provide Toyota